Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524396 | NSE: BIOFILCHEM | Trading | Small Cap

Biofil Chem & Pharma Share Price

35.60 1.40 4.09%
as on 05-Dec'25 12:05

Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524396 | NSE: BIOFILCHEM | Trading | Small Cap

DeciZen - make an informed investing decision on Biofil Chem & Pharma

Based on:

M-Cap below 100cr DeciZen not available

Biofil Chemicals & Pharmaceuticals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
19.47
Market Cap:
55.7 Cr.
52-wk low:
32.6
52-wk high:
67.5

Is Biofil Chemicals & Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Biofil Chemicals & Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Biofil Chemicals & Pharmaceuticals Ltd is a below average quality company.

2. Is Biofil Chemicals & Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Biofil Chemicals & Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Biofil Chemicals & Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Biofil Chemicals & Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Biofil Chem & Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Biofil Chemicals & Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 14%21.9%5.1%5.1%10.1%12.2%6.2%4.8%5%4.1%-
Value Creation
Index
00.6-0.6-0.6-0.3-0.1-0.6-0.7-0.7-0.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 13.213.512.423.129.735.822.4304033.443
Sales YoY Gr.-2.1%-8.1%87.1%28.4%20.4%-37.4%34.2%33.3%-16.6%-
Adj EPS 0.51.10.30.30.70.80.40.30.40.31.8
YoY Gr.-129.2%-73.6%3.5%146.7%2.7%-43.4%-20.9%29.4%-22.7%-
BVPS (₹) 4.47.88.18.49.29.910.410.611.211.513.1
Adj Net
Profit
0.81.80.50.51.21.20.70.60.70.63
Cash Flow from Ops. 0.10.70.51.30.91.1-0.2-0.12.4-1.9-
Debt/CF from Ops. 1023.41.31.30.4-2.1-4.70.2-0.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 10.9%2.4%14.3%-16.6%
Adj EPS -3.8%-14.4%-7.5%-22.7%
BVPS11.3%4.8%3.7%3.1%
Share Price 16% -33% -14% -46.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
8.115.23.63.68.584.23.34314.3
Op. Profit
Mgn %
6.619.57.64.46.14.563.922.51.3
Net Profit
Mgn %
5.913.33.82.14.13.53.11.91.81.76.7
Debt to
Equity
0.20.10.10.10.1000000
Working Cap
Days
271371397223282281262192267429195
Cash Conv.
Cycle
4331139685165741017610253

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 14.30%

Sales growth is growing at healthy rate in last 3 years 14.28%

Sales growth is good in last 4 quarters at 143.81%

Net Profit has been subdued in last 3 years -7.53%

Latest Financials - Biofil Chemicals & Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 1.8 -
TTM Sales (₹ Cr.) 42.5 -
BVPS (₹.) 13.1 -
Reserves (₹ Cr.) 5 -
P/BV 2.61 -
PE 19.47 -
From the Market
52 Week Low / High (₹) 32.60 / 67.50
All Time Low / High (₹) 0.30 / 352.45
Market Cap (₹ Cr.) 55.7
Equity (₹ Cr.) 16.3
Face Value (₹) 10
Industry PE 36.9

Management X-Ray of Biofil Chem & Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Biofil Chem & Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Biofil Chem & Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales13.1713.4512.3623.1329.6935.7522.3830.0440.0433.40
Operating Expenses 12.3010.8311.4222.1127.8734.1521.0528.8739.2232.55
Manufacturing Costs0.850.910.480.581.040.590.450.490.690.56
Material Costs10.528.519.7719.9925.3132.4319.4627.4237.5130.85
Employee Cost 0.480.530.730.890.860.750.790.450.500.61
Other Costs 0.440.880.450.640.650.380.350.510.530.54
Operating Profit 0.872.620.941.021.821.601.331.170.820.85
Operating Profit Margin (%) 6.6%19.5%7.6%4.4%6.1%4.5%6.0%3.9%2.0%2.5%
Other Income 0.530.140.100.100.170.800.150.100.490.31
Interest 0.150.160.150.160.120.070.040.040.040.04
Depreciation 0.260.280.300.370.410.410.430.430.400.38
Exceptional Items 0000000000
Profit Before Tax 0.982.310.590.601.461.921.010.790.870.74
Tax 0.200.520.120.120.260.680.320.230.160.18
Profit After Tax 0.781.790.470.481.211.240.700.560.710.56
PAT Margin (%) 5.9%13.3%3.8%2.1%4.1%3.5%3.1%1.9%1.8%1.7%
Adjusted EPS (₹)0.51.10.30.30.70.80.40.30.40.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 10.9112.7013.1713.6514.8816.1316.8417.3018.2018.78
Share Capital 16.2716.2716.2716.2716.2716.2716.2716.2716.2716.27
Reserves -5.37-3.58-3.11-2.62-1.39-0.140.561.031.932.51
Minority Interest0000000000
Debt1.371.431.561.641.190.430.460.520.440.47
Long Term Debt0000000000
Short Term Debt1.371.431.561.641.190.430.460.520.440.47
Trade Payables11.597.109.148.5825.9215.850.6012.6527.5530.99
Others Liabilities 0.260.620.290.340.370.830.830.930.890.72
Total Liabilities 24.1321.8424.1524.2142.3633.2418.7331.4147.0850.96

Fixed Assets

Gross Block11.049.459.8311.2411.4511.5511.6211.6311.6511.75
Accumulated Depreciation2.060.290.580.951.361.772.202.633.033.41
Net Fixed Assets 8.989.169.2510.2910.099.789.4298.628.34
CWIP 0000000000
Investments 0000000000
Inventories0.100.171.021.191.694.341.291.212.553.34
Trade Receivables13.9811.4612.9812.0329.7117.227.1720.5033.0338.32
Cash Equivalents 0.180.310.370.140.260.440.140.042.280.26
Others Assets 0.890.740.530.570.621.460.700.650.600.70
Total Assets 24.1321.8424.1524.2142.3633.2418.7331.4147.0850.96

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0.140.710.461.260.891.11-0.22-0.112.39-1.92
PBT 0.982.310.590.601.461.921.010.790.870.74
Adjustment 0.420.450.450.530.560.480.480.380.630.44
Changes in Working Capital -0.96-1.84-0.070.25-0.87-0.62-1.4-1.051.05-2.92
Tax Paid -0.15-0.20-0.50-0.11-0.25-0.68-0.32-0.23-0.16-0.18
Cash Flow From Investing Activity -0.19-0.48-0.38-1.41-0.21-0.10-0.07-0.01-0.02-0.10
Capex -0.19-0.48-0.38-1.41-0.21-0.10-0.07-0.01-0.02-0.10
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity 0.10-0.11-0.02-0.08-0.57-0.83-0.010.02-0.12-0
Net Proceeds from Shares 1.71000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0-0.16-0.15-0.16-0.12-0.07-0.04-0.04-0.04-0.04
Dividend Paid 0000000000
Others -1.610.060.130.08-0.45-0.760.030.06-0.080.03
Net Cash Flow 0.050.130.06-0.240.120.18-0.30-0.112.25-2.03

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)13.2818.093.643.68.468.014.243.2843.02
ROCE (%)14.0421.865.135.0610.1212.186.234.764.974.08
Asset Turnover Ratio0.70.590.540.960.890.950.861.21.020.68
PAT to CFO Conversion(x)0.180.40.982.630.740.9-0.31-0.23.37-3.43
Working Capital Days
Receivable Days244345361197257240199168244390
Inventory Days441817183146151732
Payable Days23840130316224923515488196346

Biofil Chemicals & Pharmaceuticals Ltd Stock News

Biofil Chemicals & Pharmaceuticals Ltd FAQs

The current trading price of Biofil Chem & Pharma on 05-Dec-2025 12:05 is ₹35.60.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Biofil Chem & Pharma stood at ₹55.66.
The latest P/E ratio of Biofil Chem & Pharma as of 04-Dec-2025 is 19.47.
The latest P/B ratio of Biofil Chem & Pharma as of 04-Dec-2025 is 2.61.
The 52-week high of Biofil Chem & Pharma is ₹67.50 and the 52-week low is ₹32.60.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Biofil Chem & Pharma is ₹42.52 ( Cr.) .

About Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals established in 1985, is part of Cyano Group of Industries. The company is into manufacturing of drugs in area of anti-bacterial, analgesics/antipyretics, anti-malarial, anti-psychotics, anti asthmatic/bronchodilators, diuretics, tranquilizer/hypnotics, anti inflammatory, analgesic/antipyretics, anti inflammatory steroids and eye/ear drops

Its plant is located at Plot No. 8, Sector-IV Kheda Industrial Estate, Pithampur, Dhar District, Madhya Pradesh. The facility has received GMP certificate from Licensing Authority, Food & Drugs Administration, Department of Health and Government of Madhya Pradesh, India.

The manufacturing unit exports around 30 to 40% of their formulation directly or through merchant export to countries in own or neutral labels.

The shares of companies are listed on Bombay Stock Exchange.

Company exports its products to countries namely Kenya, Uganda, Tanzania, Nigeria, U.A.E, Rwanda, Monrovia, Republic of Yemen and Mauritius.

You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×